0001171843-21-003571.txt : 20210517
0001171843-21-003571.hdr.sgml : 20210517
20210517134244
ACCESSION NUMBER: 0001171843-21-003571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210517
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POWERS JOHNNY D
CENTRAL INDEX KEY: 0001134545
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38298
FILM NUMBER: 21929288
MAIL ADDRESS:
STREET 1: C/O ZOMEDICA CORP.
STREET 2: 100 PHOENIX DRIVE, SUITE 125
CITY: ANN ARBOR
STATE: MI
ZIP: 48018
FORMER NAME:
FORMER CONFORMED NAME: POWERS JOHNNY
DATE OF NAME CHANGE: 20010212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zomedica Corp.
CENTRAL INDEX KEY: 0001684144
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PHOENIX DRIVE
STREET 2: SUITE 125
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: (734) 369-2555
MAIL ADDRESS:
STREET 1: 100 PHOENIX DRIVE
STREET 2: SUITE 125
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: Zomedica Pharmaceuticals Corp.
DATE OF NAME CHANGE: 20160908
4
1
ownership.xml
X0306
4
2021-05-17
0
0001684144
Zomedica Corp.
ZOM
0001134545
POWERS JOHNNY D
C/O ZOMEDICA CORP.
100 PHOENIX DRIVE, SUITE 125
ANN ARBOR
MI
48108
1
0
0
0
Common Stock, without par value
2021-05-17
4
M
0
125000
.26
A
1375000
D
Common Stock, without par value
2021-05-17
4
S
0
125000
0.7759
D
1250000
D
Stock option (right to buy)
0.26
2021-05-17
4
M
0
125000
0
D
2019-08-16
2021-08-16
Common Stock, without par value
125000
125000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.763 to $0.788 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
/s/ John Hogoboom, as attorney-in-fact
2021-05-17